NASDAQ:BABY - Natus Medical Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Natus Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $30.18 -0.64 (-2.08 %) (As of 02/21/2020 07:55 AM ET) Add Compare Today's Range$30.15Now: $30.18▼$31.0450-Day Range$26.75MA: $29.96▼$31.9252-Week Range$23.53Now: $30.18▼$37.90Volume110,127 shsAverage Volume165,325 shsMarket Capitalization$1.03 billionP/E Ratio21.25Dividend YieldN/ABeta0.57 ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:BABY Previous Symbol CUSIP63905010 CIK878526 Webhttp://www.natus.com/ Phone925-223-6700Debt Debt-to-Equity Ratio0.18 Current Ratio1.70 Quick Ratio1.18Price-To-Earnings Trailing P/E Ratio21.25 Forward P/E Ratio23.76 P/E GrowthN/A Sales & Book Value Annual Sales$530.89 million Price / Sales1.93 Cash Flow$3.21 per share Price / Cash Flow9.39 Book Value$11.80 per share Price / Book2.56Profitability EPS (Most Recent Fiscal Year)$1.42 Net Income$-22,930,000.00 Net Margins-7.38% Return on Equity10.79% Return on Assets6.57%Miscellaneous Employees1,729 Outstanding Shares34,010,000Market Cap$1.03 billion Next Earnings DateN/A OptionableOptionable Receive BABY News and Ratings via Email Sign-up to receive the latest news and ratings for BABY and its competitors with MarketBeat's FREE daily newsletter. Natus Medical (NASDAQ:BABY) Frequently Asked Questions What is Natus Medical's stock symbol? Natus Medical trades on the NASDAQ under the ticker symbol "BABY." How will Natus Medical's stock buyback program work? Natus Medical announced that its board has approved a share repurchase plan on Thursday, February 22nd 2018, which allows the company to repurchase $30,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company's board believes its shares are undervalued. How were Natus Medical's earnings last quarter? Natus Medical Inc (NASDAQ:BABY) posted its quarterly earnings results on Wednesday, October, 24th. The medical equipment provider reported $0.40 earnings per share for the quarter, missing the consensus estimate of $0.42 by $0.02. The medical equipment provider earned $130.60 million during the quarter, compared to analyst estimates of $132.92 million. Natus Medical had a positive return on equity of 10.79% and a negative net margin of 7.38%. Natus Medical's quarterly revenue was up 6.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.40 EPS. View Natus Medical's Earnings History. Has Natus Medical been receiving favorable news coverage? Media headlines about BABY stock have been trending somewhat positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Natus Medical earned a media sentiment score of 1.3 on InfoTrie's scale. They also assigned news headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Natus Medical. Who are some of Natus Medical's key competitors? Some companies that are related to Natus Medical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Hologic (HOLX) and Insulet (PODD). What other stocks do shareholders of Natus Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Natus Medical investors own include Starbucks (SBUX), Activision Blizzard (ATVI), Gilead Sciences (GILD), Walt Disney (DIS), Intel (INTC), Skyworks Solutions (SWKS), Celgene (CELG), AbbVie (ABBV), Alphabet (GOOG) and NVIDIA (NVDA). Who are Natus Medical's key executives? Natus Medical's management team includes the folowing people: Mr. Jonathan A. Kennedy CPA, Pres, CEO & Director (Age 48)Mr. Benjamin Drew Davies, Exec. VP & CFO (Age 53)Mr. Austin F. Noll III, Exec. VP & Chief Commercial Officer (Age 52)Mr. Seán Langan, VP Global OperationsMr. Ivan Pandiyan, VP of Global R&D Who are Natus Medical's major shareholders? Natus Medical's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Fenimore Asset Management Inc. (1.22%), Strs Ohio (0.48%), State of Alaska Department of Revenue (0.08%), Mirador Capital Partners LP (0.07%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own Natus Medical stock include Austin Francis Noll III, Dong Chune Christopher Chung, James B Hawkins, Jonathan Kennedy, Ken Ludlum, Lisa Wipperman Heine, Robert A Gunst and William M Moore. View Institutional Ownership Trends for Natus Medical. Which institutional investors are selling Natus Medical stock? BABY stock was sold by a variety of institutional investors in the last quarter, including Fenimore Asset Management Inc., Louisiana State Employees Retirement System and State of Alaska Department of Revenue. Company insiders that have sold Natus Medical company stock in the last year include Austin Francis Noll III, Dong Chune Christopher Chung, Ken Ludlum and Robert A Gunst. View Insider Buying and Selling for Natus Medical. Which institutional investors are buying Natus Medical stock? BABY stock was bought by a variety of institutional investors in the last quarter, including Strs Ohio and Mirador Capital Partners LP. View Insider Buying and Selling for Natus Medical. What is Natus Medical's stock price today? One share of BABY stock can currently be purchased for approximately $30.18. How big of a company is Natus Medical? Natus Medical has a market capitalization of $1.03 billion and generates $530.89 million in revenue each year. The medical equipment provider earns $-22,930,000.00 in net income (profit) each year or $1.42 on an earnings per share basis. Natus Medical employs 1,729 workers across the globe.View Additional Information About Natus Medical. What is Natus Medical's official website? The official website for Natus Medical is http://www.natus.com/. How can I contact Natus Medical? Natus Medical's mailing address is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. The medical equipment provider can be reached via phone at 925-223-6700 or via email at [email protected] MarketBeat Community Rating for Natus Medical (NASDAQ BABY)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 290 (Vote Outperform)Underperform Votes: 314 (Vote Underperform)Total Votes: 604MarketBeat's community ratings are surveys of what our community members think about Natus Medical and other stocks. Vote "Outperform" if you believe BABY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BABY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/21/2020 by MarketBeat.com StaffFeatured Article: What is a stock portfolio tracker?